Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial
- DOI
- 10.1186/s13020-024-01025-6
- Published
- 2024-11-04
- Container
- Chinese Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s13020-024-01025-6,
title = {Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial},
author = {Chao Deng and Qing Liu and Meng Yang and Hui-juan Cui and Yang Ge and Qin Li and Shi-jie Zhu and Guo-wang Yang and Zhi-guo Zhang and Yu Gao and Yan-ni Lou and Li-qun Jia},
year = {2024},
journal = {Chinese Medicine},
doi = {10.1186/s13020-024-01025-6},
url = {https://doi.org/10.1186/s13020-024-01025-6}
}RIS
TY - JOUR TI - Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial AU - Chao Deng AU - Qing Liu AU - Meng Yang AU - Hui-juan Cui AU - Yang Ge AU - Qin Li AU - Shi-jie Zhu AU - Guo-wang Yang AU - Zhi-guo Zhang AU - Yu Gao AU - Yan-ni Lou AU - Li-qun Jia PY - 2024 JO - Chinese Medicine DO - 10.1186/s13020-024-01025-6 UR - https://doi.org/10.1186/s13020-024-01025-6 ER -
APA
Deng, C., Liu, Q., Yang, M., Cui, H., Ge, Y., Li, Q., Zhu, S., Yang, G., Zhang, Z., Gao, Y., Lou, Y., & Jia, L. (2024). Efficacy and safety of Shengjiang Xiexin decoction on irinotecan-induced diarrhea in small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial. Chinese Medicine. https://doi.org/10.1186/s13020-024-01025-6
Source records
- crossref · retrieved 2026-09-26T11:16:17.110Z